Avadel Pharmaceuticals (AVDL)
8.03
-0.09 (-1.11%)
At close: Mar 28, 2025, 3:59 PM
8.15
1.56%
After-hours: Mar 28, 2025, 06:23 PM EDT
Avadel Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 |
| Revenue | 169.12M | 27.96M | n/a | n/a | 22.33M | 59.22M | 103.27M | 172.74M | 150.25M | 173.21M | 14.78M | 22.44M | 26.1M | 32.6M | 37.09M | 42.12M | 38.62M | 36.65M | 23.02M | 23.6M | 55.41M | 25.17M | 18.41M | 13.09M | 10.9M | 11.04M | 9.52M | 8.1M | 4.9M |
| Cost of Revenue | 15.28M | 846K | 1.49M | 815K | 5.74M | 12.13M | 17.52M | 16.3M | 13.25M | 10.92M | 3.38M | 4.35M | 5.86M | 6.28M | 6.91M | 10.12M | 9.62M | 17.32M | 6.25M | 2.52M | 3.6M | 3.68M | 2.37M | 2.17M | 1.75M | 2.09M | 3.53M | 3.1M | 400K |
| Gross Profit | 153.84M | 27.12M | -1.49M | -815K | 16.59M | 47.09M | 85.75M | 156.44M | 137M | 162.29M | 11.39M | 18.09M | 20.24M | 26.32M | 30.18M | 32M | 29M | 19.33M | 16.77M | 21.07M | 51.81M | 21.49M | 16.03M | 10.92M | 9.15M | 8.95M | 5.99M | 5M | 4.5M |
| Operating Income | -42.4M | -137.85M | -98.56M | -85.55M | -36.66M | -16.83M | -104.93M | 88.3M | -4.96M | 71.45M | -93.86M | -50.03M | -3.49M | -9.58M | -9.84M | -11.75M | -20.16M | -40.85M | -38.84M | -40.77M | 8.84M | -4.7M | -223K | -3.15M | -16.11M | -7M | -9.29M | -9M | -9M |
| Interest Income | n/a | n/a | 11.12M | 2.13M | 12.59M | 1.07M | n/a | n/a | n/a | n/a | 963K | 254K | 629K | 667K | 464K | 525K | 1.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -49.08M | -160.78M | -111.44M | -93.14M | -5.08M | -38.58M | -113.2M | 91.47M | -9.72M | 78.39M | -90.33M | -54.09M | -7.93M | -8.58M | -8.77M | -11.44M | -18.56M | -39.43M | -37.32M | -31.66M | 9.3M | -4M | 2.45M | -2.86M | -4.83M | -6.68M | -9.06M | -8.2M | -8.4M |
| Net Income | -48.83M | -160.28M | -137.46M | -77.33M | 7.03M | -33.23M | -95.3M | 67.25M | -41.28M | 40.66M | -84.91M | -42.92M | -3.23M | -8.77M | -8.97M | -11.44M | -12.08M | -37.74M | -35.2M | -27.38M | 12.5M | -3.49M | 3M | -2.87M | -9.46M | -6.69M | -7.81M | -6.8M | -6.9M |
| Selling & General & Admin | 181.04M | 151.71M | 74.52M | 68.5M | 32.41M | 30.18M | 100.36M | 58.86M | 44.18M | 21.71M | 15.7M | 13.31M | 14.15M | 10.81M | 11.33M | 13.34M | 12.91M | 16.63M | 17.38M | 14.54M | 7.61M | 5.97M | 4.02M | 3.41M | 3.46M | 3.69M | 3.63M | 3.2M | 12.6M |
| Research & Development | 15.2M | 13.26M | 20.7M | 17.1M | 20.44M | 32.92M | 39.33M | 34.22M | 34.61M | 25.61M | 17.3M | 26.69M | 26.11M | 25.09M | 28.69M | 30.42M | 36.25M | 43.56M | 38.23M | 47.3M | 35.36M | 20.22M | 12.24M | 10.66M | 9.79M | 11.05M | 10.61M | 10.1M | n/a |
| Other Expenses | n/a | n/a | 3.35M | 217K | 406K | 816K | 1.9M | 2.08M | -6.55M | n/a | -36K | 573K | 102K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 196.24M | 164.97M | 95.22M | 85.6M | 53.25M | 63.92M | 146.31M | 96.74M | 92.68M | 59.88M | 44.74M | 39.99M | 40.27M | 35.9M | 40.02M | 43.75M | 49.16M | 60.18M | 55.61M | 61.84M | 42.97M | 26.19M | 16.26M | 14.08M | 25.26M | 15.95M | 15.28M | 14M | 13.5M |
| Interest Expense | 10.83M | 9.89M | 12.34M | 9.94M | 12.99M | 12.48M | 10.62M | 1.05M | 963K | 6.3M | 9.27M | 4.35M | 118K | 73K | 24K | 100K | 18K | 16K | 35K | 68K | 45K | 29K | 49K | 52K | 51K | n/a | 95K | n/a | 100K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 211.52M | 165.81M | 95.22M | 85.6M | 58.99M | 76.04M | 163.82M | 113.04M | 105.93M | 70.81M | 48.13M | 44.34M | 46.13M | 42.18M | 46.93M | 53.87M | 58.78M | 77.5M | 61.86M | 64.37M | 46.58M | 29.87M | 18.63M | 16.24M | 27.01M | 18.04M | 18.81M | 17.1M | 13.9M |
| Income Tax | -247K | -501K | 26.02M | -15.82M | -12.11M | -5.36M | -17.89M | 24.21M | 31.56M | 37.73M | -1.41M | -11.17M | -4.7M | 192K | 209K | -6.23M | -6.48M | -1.69M | -2.12M | -4.29M | -3.2M | -503K | -553K | 14K | 50K | 16K | -1.25M | -1.4M | -1.5M |
| Shares Outstanding (Basic) | 95.14M | 80.17M | 60.09M | 58.53M | 53M | 37.4M | 37.33M | 40.47M | 41.25M | 40.58M | 36.21M | 25.41M | 24.95M | 24.67M | 24.41M | 24.23M | 24.08M | 24.02M | 23.81M | 23M | 21.51M | 17.76M | 16.2M | 16.2M | 15.33M | 12.94M | 12.05M | 10.46M | 8.63M |
| Shares Outstanding (Diluted) | 95.14M | 80.17M | 60.09M | 58.53M | 54.94M | 37.4M | 37.33M | 41.77M | 41.25M | 43.62M | 36.21M | 25.45M | 25.09M | 24.67M | 24.41M | 24.23M | 24.08M | 24.02M | 23.81M | 23M | 23.56M | 17.76M | 16.71M | 16.2M | 15.33M | 12.94M | 12.05M | 10.46M | 8.63M |
| EPS (Basic) | -0.51 | -2 | -2.29 | -1.32 | 0.13 | -0.89 | -2.55 | 1.66 | -1 | 1.00 | -2.34 | -1.69 | -0.13 | -0.36 | -0.37 | -0.47 | -0.5 | -1.57 | -1.48 | -1.19 | 0.58 | -0.2 | 0.19 | -0.18 | -0.62 | -0.52 | -0.65 | -0.65 | -0.8 |
| EPS (Diluted) | -0.51 | -2 | -2.29 | -1.32 | 0.13 | -0.89 | -2.55 | 1.61 | -1 | 0.93 | -2.34 | -1.69 | -0.13 | -0.36 | -0.37 | -0.47 | -0.5 | -1.57 | -1.48 | -1.19 | 0.53 | -0.2 | 0.18 | -0.18 | -0.62 | -0.52 | -0.65 | -0.65 | -0.8 |
| EBITDA | -35.57M | -149.13M | -97.6M | -84.78M | -34.97M | -23.61M | -95.14M | 65.89M | 5.73M | 115.54M | -94.74M | -50.03M | -8.36M | -5.16M | -4.05M | -5.42M | -11.29M | -33.22M | -33.2M | -36.03M | 9.34M | -2.99M | 1.24M | -1.89M | -14.99M | -5.79M | -8.25M | -8.3M | -8.1M |
| Depreciation & Amortization | 2.68M | 1.77M | 1.49M | 815K | 1.69M | 2.49M | 7.43M | 4.88M | 14.49M | 13.13M | 14.14M | 3.06M | 3.18M | 3.35M | 4.7M | 5.92M | 7.25M | 6.2M | 5.64M | 4.74M | 2.53M | 1.71M | 1.46M | 1.27M | 1.11M | 1.21M | 1.04M | 700K | 900K |